These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15476674)

  • 1. A novel cancer therapy: combined liposomal hypoxia inducible factor 1 alpha antisense oligonucleotides and an anticancer drug.
    Wang Y; Minko T
    Biochem Pharmacol; 2004 Nov; 68(10):2031-42. PubMed ID: 15476674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system.
    Pakunlu RI; Wang Y; Tsao W; Pozharov V; Cook TJ; Minko T
    Cancer Res; 2004 Sep; 64(17):6214-24. PubMed ID: 15342407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin.
    Pakunlu RI; Cook TJ; Minko T
    Pharm Res; 2003 Mar; 20(3):351-9. PubMed ID: 12669953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor.
    Wang Y; Saad M; Pakunlu RI; Khandare JJ; Garbuzenko OB; Vetcher AA; Soldatenkov VA; Pozharov VP; Minko T
    Clin Cancer Res; 2008 Jun; 14(11):3607-16. PubMed ID: 18519795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug.
    Pakunlu RI; Wang Y; Saad M; Khandare JJ; Starovoytov V; Minko T
    J Control Release; 2006 Aug; 114(2):153-62. PubMed ID: 16889867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimodal effect of hypoxia in cancer: role of hypoxia inducible factor in apoptosis.
    Wang Y; Pakunlu RI; Tsao W; Pozharov V; Minko T
    Mol Pharm; 2004; 1(2):156-65. PubMed ID: 15832512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming multidrug resistance using liposomal epirubicin and antisense oligonucleotides targeting pump and nonpump resistances in vitro and in vivo.
    Lo YL; Liu Y; Tsai JC
    Biomed Pharmacother; 2013 May; 67(4):261-7. PubMed ID: 23540284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
    Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase.
    Guin S; Ma Q; Padhye S; Zhou YQ; Yao HP; Wang MH
    Cancer Chemother Pharmacol; 2011 May; 67(5):1073-83. PubMed ID: 20658288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
    Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
    Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.
    Lo YL; Liu Y
    PLoS One; 2014; 9(3):e90180. PubMed ID: 24637737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK1 as a molecular target to limit cellular mortality under hypoxia.
    Betigeri S; Pakunlu RI; Wang Y; Khandare JJ; Minko T
    Mol Pharm; 2006; 3(4):424-30. PubMed ID: 16889436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-Functionalized DNA Origami for Targeted Codelivery of Antisense Oligonucleotides and Doxorubicin to Enhance Therapy in Drug-Resistant Cancer Cells.
    Pan Q; Nie C; Hu Y; Yi J; Liu C; Zhang J; He M; He M; Chen T; Chu X
    ACS Appl Mater Interfaces; 2020 Jan; 12(1):400-409. PubMed ID: 31815420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
    Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas.
    Zhang Q; Zhang ZF; Rao JY; Sato JD; Brown J; Messadi DV; Le AD
    Int J Cancer; 2004 Oct; 111(6):849-57. PubMed ID: 15300796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.
    Lopes de Menezes DE; Hudon N; McIntosh N; Mayer LD
    Clin Cancer Res; 2000 Jul; 6(7):2891-902. PubMed ID: 10914739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice.
    Mainelis G; Seshadri S; Garbuzenko OB; Han T; Wang Z; Minko T
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):345-54. PubMed ID: 23530772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
    Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.